ūüďě  +1 (855) 661-4441(US)   ūüďě  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Benzodiazepine Market Research Report Information, By Applications (anxiety, insomnia, agitation, seizures, muscle spasms, alcohol withdrawal symptoms), By time of action (Long acting, Short acting), - Forecast Till 2032

ID: MRFR/Pharma/1674-HCR | 85 Pages | Author: Rahul Gotadki| June 2024

Global Benzodiazepine Market Overview

Global benzodiazepine market size was valued at USD 1.74 billion in 2022. The global market is projected to grow from USD 1.88 billion in 2023 to USD 3.67 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.90% during the forecast period (2023 - 2032). The Benzodiazepine belongs to the psychoactive class of drugs. It is basically used for treating various mental diseases such as panic disorder, anxiety, alcohol withdrawal, seizures, and others.

Benzodiazepine Market

They also have sedation properties which are also helpful in general anaesthesia, seizures, agitation, muscle spasms, etc. In the years 2005-2008, around 11% of Americans above 12 years of age took medicines for anxiety treatment. Also, the improvement of Xanax and healthcare programs improved the Market Growth. According to the Benzodiazepine Industry Analysis by the International Control Board, India (19%), Germany (10%), Italy (32%), and China (11%) were among the notable manufacturers of benzodiazepine.

COVID-19 Analysis

The COVID-19 disease started to spread across the world in late 2019 and the initial months of 2020. It led to the financial disruption of various countries across the world. It created a huge gap between medical care and the demand for psychological management. Also, the use of required medication for COVOD-1 treatment caused negative drug interaction. Therefore, the Benzodiazepine Market was significantly disturbed with the advent of COVID-19 disease

Benzodiazepine Market Trends

Market Drivers

The increasing cases of mental disorders across various countries across the world are anticipated to drive the Benzodiazepine Market. Also, the growing population of the older generation suffering from various mental disorders such as insomnia, Alzheimer's, etc. will further enhance the Industry Growth in the upcoming years.


The side effects of the benzodiazepine medicines are considered to be a major restraint for the market. Along with that, the higher chances of drug misuse and dependence on these medicines can further lead to death. Therefore, these restraints can be a significant threat to the market growth.


The adoption of a sedentary lifestyle can lead to various mental disorders such as agitation, anxiety, and many more. Therefore, with these types of rising cases, the Benzodiazepine Market will grow at a notable rate.


The availability of other alternatives of benzodiazepine drugs can be challenging for the market to compete. Also, a poor supply chain and lack of skilled workers can slow down the production of these medicines.

Value Chain Analysis

The increasing cases of mental disorders in the past several years are anticipated to emerge as a great advantage. It has further improved the market trends that will improve the market growth simultaneously. Also, the developments, acquisitions, mergers, etc. by key players will be further evaluated to propel the market growth.

Benzodiazepine Market Segment Insights

The Benzodiazepine Market segments are divided into product, application, and time of action. Based on application, the Market is segmented into Insomnia, Anxiety Disorders, Alcohol Withdrawal, Seizures, Agitation, Muscle Spasms, Anaesthesia Supplements, and Others.

Based on Product Type, the Market is bifurcated into Diazepam, Alprazolam, Clonazepam, and Lorazepam.

Based on Action Time, the Benzodiazepine Market is divided into Ultra-Short Acting, Long Acting, and Short-Acting.

Benzodiazepine Regional Insights

Based on geography, the Benzodiazepine Market Size is segmented into the Americas, Asia-pacific, Africa and the Middle East, and Europe. The Americas is divided into North America and Latin America. North America is anticipated to hold the largest share in the market. The significant technological development, better healthcare infrastructure are some crucial reasons for the largest share.

Secondly, Europe is depicted to hold the second-largest market share in the forecast period. The growing investments for development and research are the drivers of this region.

On the other hand, the Asia-Pacific region is evaluated to witness the fastest market growth in the studied forecast period. China, India, South Korea are playing a crucial role in boosting market growth in the future years.

Lastly, Africa and the Middle East region will also have notable growth in the upcoming years. The gradual development and growing awareness in this region can improve the market growth.

Key Companies in the Benzodiazepine market include

The Benzodiazepine Market is fragmented with the presence of various key players. These key players apply various market strategies such as partnerships, new product launches, market analysis, mergers, and many more. These strategies help the key players to enhance their business portfolio and geographical withhold. Some of the key players in the Benzodiazepine Market are listed below.

  • AstraZeneca

  • Merck & Co. Inc.

  • Forest Laboratories

  • Lundbeck A/S

  • Johnson& Johnsons

  • GlaxoSmithKline Plc

  • Pfizer Inc.

  • Mylan N.V.

  • Hoffman-La Roche Ltd.

  • Teva Pharmaceutical Industries Ltd.

  • Bausch Health Companies, Inc.

  • Amneal Pharmaceuticals LLC

  • Apotex Inc.

  • Eli Lily and Company

  • Sun Pharmaceutical Industries

  • Aurobindo Pharma

  • Apotex Inc.

Recent Developments

In August 2023,Lundbeck A/S Presented Phase 2 data for LX10333, a next-generation benzodiazepine-derived positive allosteric modulator (PAM) of alpha-7 nicotinic acetylcholine receptors, at the 2023 Alzheimer's Association International Conference (AAIC) for the treatment of cognitive decline in mild-to-moderate Alzheimer's disease (AD).
Report Overview

The report overview of the Benzodiazepine Market Analysis is listed below.

  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development

Benzodiazepine Market Segmentation

Benzodiazepine Application Outlook

  • Insomnia

  • Anxiety Disorders

  • Alcohol Withdrawal

  • Seizures

  • Agitation

  • Muscle Spasms

  • Anaesthesia Supplements

  • Others

Benzodiazepine Product Outlook

  • Diazepam

  • Alprazolam

  • Clonazepam

  • Lorazepam

Benzodiazepine Action Time Outlook

  • Ultra-Short Acting

  • Long-Acting

  • Short-Acting

Benzodiazepine Region Outlook

  • Asia-Pacific

  • Americas

  • Africa and the Middle East

  • Europe

Report Attribute/Metric Details
  Market Size (2032)   3.67 Billion
  CAGR   6.90%
  Base Year   2022
  Forecast Period   2023-2032
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Applications, Time of action
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   AstraZeneca plc, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer, Inc., Sanofi S.A. and Merck & Co., Inc.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers ·  Rise in Prevalence of Anxiety disorders, Seizures and Insomnia Diseases·  Rise in Adoption of Generic Drugs

Frequently Asked Questions (FAQ) :

Benzodiazepine market is projected grow at approximately 6.90% CAGR during the assessment period (2023-2032).

Growing prevalence of anxiety and insomnia and government funding support for R&D are the major tailwinds pushing the growth of the global Benzodiazepine market

North America holds the largest share in the global Benzodiazepine market, followed by Europe and the Asia Pacific, respectively.

Eli Lilly and Company, AstraZeneca plc, Forest Laboratories, Inc., H. GlaxoSmithKline plc, Lundbeck A/S, Merck & Co., Inc., Johnson & Johnson, Sanofi S.A., and Pfizer, Inc., are some of the major players operating in the Benzodiazepine market.

Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global market adopt to gain a larger competitive advantage.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.